Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PureTech Health ADR | PRTC | Apr 24, 2024 | 27.48 | +5.09 |
Purple Biotech ADR | PPBT | Apr 24, 2024 | 0.51 | +4.63 |
Purple Innovation | PRPL | Apr 24, 2024 | 1.53 | -4.38 |
Putnam Managed Municipal Income Trust | PMM | Apr 24, 2024 | 5.88 | -0.34 |
Putnam Master Intermediate Income Trust | PIM | Apr 24, 2024 | 3.09 | -0.64 |
Putnam Municipal Opportunities Trust | PMO | Apr 24, 2024 | 9.79 | -0.31 |
Putnam Premier Income Trust | PPT | Apr 24, 2024 | 3.44 | -1.43 |
PVH | PVH | Apr 24, 2024 | 112.87 | +0.20 |
Pyrophyte Acquisition | PHYT | Apr 24, 2024 | 11.33 | 0.00 |
Pyxis Oncology | PYXS | Apr 24, 2024 | 4.45 | -1.11 |
Pyxis Tankers | PXS | Apr 24, 2024 | 4.47 | -0.67 |
Pyxis Tankers Pref | PXSAP | Apr 24, 2024 | 24.55 | -0.43 |
Q2 | QTWO | Apr 24, 2024 | 53.78 | +0.73 |
Q32 Bio | QTTB | Apr 24, 2024 | 26.59 | 0.00 |
QCR | QCRH | Apr 24, 2024 | 58.57 | +0.36 |
QIAGEN | QGEN | Apr 24, 2024 | 41.52 | -0.88 |
Qifu Technology ADR | QFIN | Apr 24, 2024 | 18.73 | +1.19 |
Qilian International | QLI | Apr 24, 2024 | 0.79 | +7.43 |
Qomolangma Acquisition | QOMO | Apr 24, 2024 | 10.81 | 0.00 |
Qorvo | QRVO | Apr 24, 2024 | 112.15 | +3.86 |
QT Imaging | QTI | Apr 24, 2024 | 0.87 | 0.00 |
Quad Graphics A | QUAD | Apr 24, 2024 | 4.66 | -2.71 |
Quadro Acquisition One | QDRO | Apr 24, 2024 | 11.03 | -0.09 |
Quadro Acquisition One Unit | QDROU | Apr 24, 2024 | 11.05 | 0.00 |
Quaker Houghton | KWR | Apr 24, 2024 | 189.92 | -0.74 |
QUALCOMM | QCOM | Apr 24, 2024 | 163.63 | +1.41 |
Qualigen Therapeutics | QLGN | Apr 24, 2024 | 0.31 | -1.94 |
Qualys | QLYS | Apr 24, 2024 | 172.11 | +0.33 |
Quanex Building Products | NX | Apr 24, 2024 | 33.70 | -3.02 |
Quanta Services | PWR | Apr 24, 2024 | 253.18 | +0.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.